Pharmaceutical company Teva USA announced today that it will resume production of childhood cancer drug vincristine after a recent shortage which led to patients missing doses of the vital chemotherapy.
Teva Pharmaceuticals To Resume Production Of Scarce Childhood Cancer Drug Vincristine
